S2VAScscore( 73.0%VS.94.8%,X2=131.00,P<0.001,Kappa=0.257) .Concl usi onCH AD S2 score,CH A2 D S2- VAScscorenonval vul ar atri alfi bri l l ati on.【Key w ords】fi bri l l ati on;Stroke;category pati entsscorescoregroup,andthe consi stence betw een the t w o scores w ...
临床预后CHADS2和CHA2DS2-VASc评分是非瓣膜性心房颤动患者卒中风险分层和指导抗凝治疗的常用工具.最近研究发现上述评分亦可用于预测非心房颤动患者卒中,不良心血管事件和死亡风险以及临床预后.现就CHADS2和CHA2DS 2-VASe评分相关的临床最新应用做一综述.%CHADS2 and CHA2DS2-VASc score are widely applied stroke ...
Erlinge D, Kristensen SD, Maeng M. Dual antithrombotic treatment in chronic coronary syndrome: European Society of Cardiology criteria vs. CHADS-P2A2RC score. Eur Heart J. 2021 Dec 6:ehab785. doi: 10.1093/eurheartj/ehab785. Epub ahead of print. PMID: 34871376....
Furthermore, a higher CHADS-VASc score results in an increased risk of left atrial appendage (LAA) thrombus (3). In this study, we sought to investigate the association between CHADS-VASc score and the development of LAA thrombus in patients with ATTR-CA and AF. We analyzed a retrospective...
CHA2DS2-VASc score stratifies mortality risk in patients with and without atrial fibrillation Serge C Harb, Open Heart, 2021 Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2and CHA2DS2-VASc scores Marianne Patt, Danielle Southern, Diane Galbraith, et al., Heart...
最新研究认为CHA2DS2-VASc评分较CHADS2评分更为完善,对NVAF患者卒中风险有更好的预测作用,但目前国内外有关其在NVAF缺血性脑卒中患者中的临床应用的资料较少。问题补充:匿名 2013-05-23 12:21:38 The latest studies suggest that the the the cha2ds2-vasc score chads2 score is more perfect, the nvaf...
cha2ds2-vasc和chads2评分在冠心病外科治疗中的应用,cha2ds2 vasc评分,chads2,冠心病score评分,冠心病,冠心病的症状,冠心病早期症状,冠心病偏方,冠心病能治好吗,冠心病吃什么食物好 文档格式: .pdf 文档大小: 1.06M 文档页数: 2页 顶/踩数: 0/0 收藏人数: ...
CHADS(2) scoreCHA(2)DS-VASc scoreAtrial fibrillationIschemic strokeIntracranial hemorrhageCurrent risk schemes to predict ischemic stroke and intracranial ... CW Siu,GYH Lip,KF Lam,... - 《Heart Rhythm》 被引量: 85发表: 2014年 The prevalence of atrial fibrillation in a geographically well‐defi...
ConclusionCMBs is strongly associated with CHA2DS2-VASc score in patients with NVAF.Age and anticoagulant therapy are its independent risk factors.It is necessary to detect the possibility of CMBs in old NVAF patients with high CHA2DS2-VASc score before and during anticoagulant therapy. KEYWORDS: ...
There are also LA/LAA thrombus in low-moderate risk patients when us⁃ing the two score systems, and with the increased risk stratification, the rate of LA/LAA thrombus is increased.%目的:探讨CHADS2及CHA2DS2-VASc评分对非瓣膜性心房颤动(房颤)患者左心房(LA)/左心耳(LAA)血栓的预测价值。